Insider Shareholders with Direct Ownership of Kymera Therapeutics, Inc. (KYMR)
This section provides a comprehensive overview of the insiders with direct ownership of Kymera Therapeutics, Inc. (KYMR). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Kymera Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
| 0 | 3,272,907 | 5,066,925 $223 Million | 14 |
Dec 15, 2022
Reduced 0.05%
|
|
|
Nello Mainolfi
Chief Executive Officer |
581,918 | 312,000 | 649,959 $28.6 Million | 66 |
Jul 01, 2024
Added 2.81%
|
|
Bvf Partners L P
Director |
5,054,902 | 0 | 294,632 $13 Million | 15 |
Nov 03, 2023
Added 3.32%
|
|
Bruce N. Jacobs
Chief Financial Officer |
245,300 | 100,304 | 168,554 $7.42 Million | 28 |
Jun 27, 2024
Added 12.92%
|
|
Jared Gollob
Chief Medical Officer |
211,465 | 223,272 | 95,470 $4.21 Million | 28 |
Jul 16, 2024
Reduced 9.36%
|
|
Ellen Chiniara
Chief Legal Officer |
59,255 | 3,295 | 55,960 $2.47 Million | 3 |
Mar 01, 2024
Added 27.99%
|
|
Jeremy G Chadwick
Chief Operating Officer |
46,758 | 2,575 | 44,183 $1.95 Million | 3 |
May 23, 2024
Reduced 5.51%
|
|
Elaine Caughey
Chief Business Officer |
17,557 | 714 | 18,986 $836,333 | 3 |
Mar 02, 2023
Reduced 0.86%
|
| 8,500 | 8,500 | 0 $0 | 2 |
Jun 07, 2024
Reduced 100.0%
|
|
| 20,000 | 20,000 | 0 $0 | 8 |
Aug 26, 2024
Reduced 100.0%
|
|
| 13,500 | 13,500 | 0 $0 | 2 |
Sep 17, 2024
Reduced 100.0%
|
|
|
Richard Chesworth
Chief Scientific Officer |
87,779 | 87,779 | 0 $0 | 4 |
Aug 27, 2021
Reduced 100.0%
|
|
Atlas Venture Associates X, L.P.
> 10% Shareholder |
0 | 471,483 | 0 $0 | 2 |
Aug 11, 2021
Reduced 100.0%
|